Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells

PURPOSE: Ovarian cancer is the most lethal malignancy in gynecology. Due to limited treatment strategies and platinum resistance, newer drugs and therapeutic options are needed. Esomeprazole (ESO) has been reported to have multiple anticancer activities in preclinical and clinical research. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Jingya, Zhang, Zisen, Du, Jinfeng, Zhang, Jihua, Li, Minmin, Li, Canyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290496/
https://www.ncbi.nlm.nih.gov/pubmed/37359351
http://dx.doi.org/10.2147/OTT.S406009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290496/
https://www.ncbi.nlm.nih.gov/pubmed/37359351
http://dx.doi.org/10.2147/OTT.S406009

Ejemplares similares